Osteoprotegerin: a novel independent marker for silent myocardial ischemia in asymptomatic diabetic patients.
about
Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular DiseaseRelation of multiple inflammatory biomarkers to incident atrial fibrillation.Can Brain Natriuretic Peptides and Osteoprotegerin Serve As Biochemical Markers for the Detection of Aortic Pathology in Children and Adolescents with Turner Syndrome?The ECG vertigo in diabetes and cardiac autonomic neuropathy.Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus.Osteoprotegerin in Cardiometabolic Disorders.Osteoprotegerin as a marker of atherosclerosis in diabetic patients.Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study.Osteoprotegerin, vascular calcification and atherosclerosis.Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression ModelCoronary calcification and hormones.The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology - a review.Identification of Predictable Biomarkers in Conjunction to Framingham Risk Score to Predict the Risk for Cardiovascular disease (CVD) in Non Cardiac Subjects.Evolution of silent myocardial ischaemia prevalence and cardiovascular disease risk factor management in Type 2 diabetes over a 10-year period: an observational study.Serum osteoprotegerin in prevalent hemodialysis patients: associations with mortality, atherosclerosis and cardiac function.Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men.Elevated serum osteoprotegerin may predict peripheral arterial disease after kidney transplantation: a single-center prospective cross-sectional study in Taiwan.Osteoprotegerin, leptin and IL-6: association with silent myocardial ischemia in type 2 diabetes mellitus.A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients.Effects of pravastatin on serum osteoprotegerin levels in patients with hypercholesterolemia and type 2 diabetes.The association of insulin resistance with serum osteoprotegerin in obese adolescents.The Role of Osteoprotegerin as a Cardioprotective Versus Reactive Inflammatory Marker: the Chicken or the Egg Paradox
P2860
Q26747224-097114E5-B506-417B-B569-C1F274F952A8Q33573035-23C2EE19-9C27-4638-8450-364514663582Q33867461-439B600B-2C2F-4024-A983-CC6140AD3C76Q35071142-F29D0273-1C9D-4913-A80E-3E2C8CEC37B3Q35185705-D30601D7-B3D5-4FDA-B8FA-AABBEC2415FBQ35640787-DC2BB490-2668-414D-B925-8A1B404433A1Q36582644-0E58912C-D0CB-446D-988C-62D14F509E0AQ37119482-D2528EFE-C441-4083-B034-67C818A7D607Q37310825-AF997354-80A3-41B8-B6D8-61A4DE9A0CE6Q37645133-E756A238-50A0-4F35-A4CF-E3EADB4F4CEAQ37855315-0F2D9F42-6CCD-44EE-81C1-722F31B0A1C6Q37922640-3DAB609A-6832-465B-B9D7-412775C86FDAQ40161318-D4501771-E4D4-4502-B7D4-3FA6C3B64144Q40238177-5E73C41A-0210-4F40-BCB6-F2496C2FCC8FQ41524527-F5158F57-7055-43B0-A7F1-A2B8C77A19A9Q42013167-8E985ED2-9C78-4CBB-B0B7-E32BDFBCBB84Q42278602-4DD60999-4BBC-42A4-A164-2FA5BB773F26Q44967650-494CA157-5A75-4FDB-AAD2-DBE4B3DB2836Q45941637-D07EB7BE-D06B-4115-83FB-9EADBD9E026FQ46160839-C79B34E5-BCD3-45CE-A7AF-11F78C71292DQ50972479-35960B09-D873-4C4E-AEE4-1F2A08126CC1Q55285084-B0AAF3DF-A221-4758-AD9B-4862ABE667B2
P2860
Osteoprotegerin: a novel independent marker for silent myocardial ischemia in asymptomatic diabetic patients.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Osteoprotegerin: a novel indep ...... symptomatic diabetic patients.
@en
Osteoprotegerin: a novel indep ...... symptomatic diabetic patients.
@nl
type
label
Osteoprotegerin: a novel indep ...... symptomatic diabetic patients.
@en
Osteoprotegerin: a novel indep ...... symptomatic diabetic patients.
@nl
prefLabel
Osteoprotegerin: a novel indep ...... symptomatic diabetic patients.
@en
Osteoprotegerin: a novel indep ...... symptomatic diabetic patients.
@nl
P2093
P50
P356
P1433
P1476
Osteoprotegerin: a novel indep ...... asymptomatic diabetic patients
@en
P2093
Antoine Avignon
Ariane Sultan
Jean Paul Cristol
Jean-François Thuan Dit Dieudonné
P304
P356
10.2337/DC07-0992
P407
P577
2007-08-21T00:00:00Z